Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2026-02-08 @ 1:32 PM
Study NCT ID:
NCT01850602
Status:
COMPLETED
Last Update Posted:
2018-10-09
First Post:
2013-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Sponsor:
Kissei Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PA1301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None